Cancer Epidemiology: Low- and Middle-Income Countries and Special Populations

According to the World Health Organization's 2008 GLOBOCAN report, 64% of global cancer deaths -- and 56% of cancer cases -- were registered in countries in Africa, Asia, or Latin America. So while cancer is unquestionably a global burden, its reach in the developing world points to the need for specialized study on cancer in these countries.

Cancer Epidemiology: Low- and Middle-Income Countries and Special Populations reviews the current status of cancer epidemiologic research and training -- rationale, requisite infrastructure, methodologic principles, and illustrative examples in low- and middle-income countries -- in order to facilitate future advances by trained health professionals. The result is a valuable resource for both program leaders and graduate and post-graduate students pursuing careers in international cancer epidemiologic research.

Amr Soliman, MD, PhD, is Professor and Chair of Epidemiology, University of Nebraska Medical Center.

David Schottenfeld, MD, MSc, is the Searle Professor Emeritus and former Chair of the Department of Epidemiology, University of Michigan.

Paolo Boffetta, MD, MPH, is Director of the Institute for Translational Epidemiology and Associate Director of Population Sciences, Tisch Cancer Institute at Mount Sinai Hospital.